Eiger BioPharmaceuticals (EIGR) Files Chapter 11

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. NVDA
2. PTC
3. PCVX
4. META
5. RXO
6. USO
7. AMD
8. SPY
9. MSFT
10. GOOGL

Go back to Eiger BioPharmaceuticals (EIGR) Files Chapter 11

Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection

April 1, 2024 11:12 AM EDT

Announces Stalking Horse Agreement for the Sale of Zokinvy® (lonafarnib)

Patient Access to Zokinvy® to Continue Uninterrupted

PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR) today announced that it and its direct subsidiaries have filed voluntary petitions for chapter 11 protection under the United States Bankruptcy Code in the United States Bankruptcy Court for the Northern District of Texas. The company also announced a stalking horse agreement for the sale of Zokinvy® (lonafarnib) to Sentynl Therapeutics, Inc., a biopharmaceutical... More